Predicting the timing of first sustained cognitive worsening in Alzheimer’s disease using real-world clinical data and machine learning

Read full text
Authors: Shruthi Venkatesh, Sinian Zhang, Wen Zhu, Michèle Morris, Rocco B Mercurio, Sarah B. Berman, Hansruedi Mathys, Abby L. Olsen, C. Elizabeth Shaaban, Shyam Visweswaran, Oscar L. Lopez, Tianxi Cai
+2 more Jue Hou, Zongqi Xia
Cited by: 1
References: 50

Abstract

ABSTRACT Background Cognitive assessments are sparsely documented in electronic health records (EHRs), limiting scalable detection of cognitive worsening in real-world clinical settings. Methods We applied a deep neural network optimized for identifying clinical event timing from sparsely labeled gold-standard data ( label-efficient incident phenotyping from longitudinal EHR , LATTE) to predict time-to-first sustained cognitive worsening in AD patients from a large healthcare system (2011–2022) with linkage to an AD Research Center registry in a subset. Sustained cognitive worsening was defined as cognitive decline persisting over ≥2 consecutive visits within 3 years. Separate LATTE models were trained with worsening labels from Clinical Dementia Rating (CDR), Mini-Mental Status Examination (MMSE), and Montreal Cognitive Assessment (MoCA) scores; semi-supervised learning scaled predictions to larger imputation cohorts lacking sufficient longitudinal scores. We evaluated model performance using average time-specific area under the receiver operating characteristic curve (AUC), area between curves (ABC), and Brier scores. To demonstrate clinical utility, we examined whether predicted time-to-worsening differentiated clinically meaningful patient subgroups using competing-risk Cox proportional hazards models accounting for death. Findings The cohort comprised 27,614 AD patients (65% women, 91% non-Hispanic White, mean [SD] age at start of follow-up 78.76 [9.53] years). In gold-standard cohorts (n: CDR=632, MMSE=710, MoCA=752; remaining patients formed imputation cohorts), LATTE demonstrated robust predictive performance (average time-AUC: CDR 0.816, MMSE 0.694, MoCA 0.710; ABC: CDR 0.067, MMSE 0.293, MoCA 0.078; Brier score: CDR 0.252, MMSE 0.437, MoCA 0.295). APOE -ε4 carriers had shorter predicted time-to-worsening compared to non-carriers across all assessments in the imputation cohorts (HRs 1.241–1.376, all p

Fields of Study & Subjects

Dementia and Cognitive Impairment Research Machine Learning in Healthcare Intensive Care Unit Cognitive Disorders

Publication details

Journal / source
medRxiv
Publisher
openRxiv
Publication date
4 June 2026
Language
EN
Document type
Preprint